#icodec

Gute Pillen – Schlechte Pillen

@gpspmagazin.bsky.social

4 months ago

Insulin icodec bei Diabetes - Gute Pillen - Schlechte Pillen Gegenüber herkömmlichem Insulin hat das neue teurere Mittel Insulin icodec keine Vorteile. Unterzuckerungen sind jedoch häufiger.

#Weltdiabetestag: Insulin icodec ist neu, aber auch besser? Die Arzneimittelkommission der deutschen Ärzteschaft sieht wegen der häufigeren Unterzuckerungen bei Typ-1-#Diabetes sogar Anhaltspunkte für einen geringeren Nutzen von #Insulin #icodec. (€)

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social

9 months ago

Once‑weekly IcoSema versus once‑weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial In adults with inadequately controlled type 2 diabetes on daily basal insulin therapy, once‑weekly IcoSema showed superiority to once-weekly icodec alone in changes in HbA1c and in overall lower rate ...

New—Once‑weekly #IcoSema versus once‑weekly #insulin #icodec in type 2 #diabetes management (COMBINE 1): an open‑label, multicentre, treat‑to‑target, randomised, phase 3a trial thelancet.com/journals/lan... #T2D

#MedSky #EndoSky

Katherine Thomasset

@kaththomasset.bsky.social

1 year ago

A combination of #insulin #icodec and #semaglutide, led to superior reduction in HbA1c after 52 wks vs once-weekly #semaglutide in the #COMBINE_2 study #DiabetesResearch #Endocrinology #MedSky

Diabetologia

@diabetologiajnl.bsky.social

1 year ago

Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial - Diabetologia Aims/hypothesis COMBINE 2 assessed the efficacy and safety of once-weekly IcoSema (a combination therapy of basal insulin icodec and semaglutide) vs once-weekly semaglutide (a glucagon-like peptide-1 ...

In adults with #T2D in #COMBINE_2, #once-weekly #IcoSema, a combination of #icodec and #semaglutide, led to superior reduction in HbA1c after 52 wks vs once-weekly #semaglutide, with similar #hypoglycaemia rates, but weight change favoured semaglutide tinyurl.com/b3uwndny 🔓

European Association for the Study of Diabetes

@easdnews.bsky.social

1 year ago

Should everyone switch from once-daily insulins to #icodec or #efsitora?

#EASD Board Member Julia Mader lets you know who would benefit from once-weekly #insulins, discussing the latest data (#QWINT2) in this Expert Insights ep.

🎥👉https://easd-elearning.eu/Expert_Insights_14.html

#diabetes

RedGDPS

@redgdps.bsky.social

1 year ago

Nuevas Insulinas semanales en #congresoRedgdps con @GMNdoc #GelyAlvarez
#ICODEC #AWIQLI